Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 213, Issue 9, Pages 1723-1740
Publisher
Rockefeller University Press
Online
2016-08-01
DOI
10.1084/jem.20160283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice
- (2015) Nehemiah Cox et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
- (2014) R. Rampal et al. BLOOD
- Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms
- (2014) Lorena Arranz et al. NATURE
- Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis
- (2014) I. Triviai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paracrine functions of fibrocytes to promote lung fibrosis
- (2014) Kathryn R Kleaveland et al. Expert Review of Respiratory Medicine
- Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
- (2013) H. Zhang et al. BLOOD
- Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model
- (2013) Barbara Reich et al. KIDNEY INTERNATIONAL
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Population of Cells Expressing Both Hematopoietic and Mesenchymal Markers Is Present in the Normal Adult Bone Marrow and Is Augmented in a Murine Model of Marrow Fibrosis
- (2011) Masanobu Ohishi et al. AMERICAN JOURNAL OF PATHOLOGY
- High and Low Molecular Weight Hyaluronic Acid Differentially Regulate Human Fibrocyte Differentiation
- (2011) Anu S. Maharjan et al. PLoS One
- Loss of Indian Hedgehog Activates Multiple Aspects of a Wound Healing Response in the Mouse Intestine
- (2010) Willemijn A. van Dop et al. GASTROENTEROLOGY
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
- (2010) Lynne A. Murray et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
- (2010) Alfonso Quintás-Cardama et al. INVESTIGATIONAL NEW DRUGS
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated View of Humoral Innate Immunity: Pentraxins as a Paradigm
- (2009) Barbara Bottazzi et al. Annual Review of Immunology
- Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts
- (2009) Darrell Pilling et al. PLoS One
- Serum Amyloid P Inhibits Fibrosis Through Fc R-Dependent Monocyte-Macrophage Regulation in Vivo
- (2009) A. P. Castano et al. Science Translational Medicine
- Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells
- (2008) S. B. Haudek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More